Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hossann

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 20, 2021
Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol studyWouter J M Lokerse, Artur Lazarian, Alisa Kleinhempel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 26, 2013
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacyLi Li, Timo L M ten Hagen, Martin Hossann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2010
Size of thermosensitive liposomes influences content releaseMartin Hossann, Tungte Wang, Michael Wiggenhorn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2015
Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumorsLinus Willerding, Simone Limmer, Martin Hossann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2025
The effect of hyperthermic cycling on intratumoral liposome accumulation and triggered drug releaseLi Li, Marjolein I Priester, Christian Rossmann, et al.
International Journal of Nanomedicine|January 15, 2021
DPPG<sub>2</sub>-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder CancerF Johannes P van Valenberg, Iris S G Brummelhuis, Lars H Lindner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 6, 2016
A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcomaKatja Zimmermann, Martin Hossann, Johannes Hirschberger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2022
Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig modelLukas Christian Sebeke, Juan Daniel Castillo Gómez, Edwin Heijman, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 20, 2021
Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol studyWouter J M Lokerse, Artur Lazarian, Alisa Kleinhempel, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 26, 2013
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacyLi Li, Timo L M ten Hagen, Martin Hossann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2010
Size of thermosensitive liposomes influences content releaseMartin Hossann, Tungte Wang, Michael Wiggenhorn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2015
Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumorsLinus Willerding, Simone Limmer, Martin Hossann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2025
The effect of hyperthermic cycling on intratumoral liposome accumulation and triggered drug releaseLi Li, Marjolein I Priester, Christian Rossmann, et al.
International Journal of Nanomedicine|January 15, 2021
DPPG<sub>2</sub>-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder CancerF Johannes P van Valenberg, Iris S G Brummelhuis, Lars H Lindner, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 6, 2016
A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcomaKatja Zimmermann, Martin Hossann, Johannes Hirschberger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2022
Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig modelLukas Christian Sebeke, Juan Daniel Castillo Gómez, Edwin Heijman, et al.
Pageof 3